Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Pleuronectes pinnifasciatus" patented technology

Preparation method of APP (Actinobacillus Pleuropneumoniae) OMVs (Outer Membrane Vesicles) and vaccine of APP OMVs

ActiveCN105420161AExperimental evaluation of immunostimulatory effectsAssessing immunostimulatory effectsAntibacterial agentsBacterial antigen ingredientsIMMUNE STIMULANTSFiltration
The invention relates to a preparation method of APP (Actinobacillus Pleuropneumoniae) OMVs (Outer Membrane Vesicles) and a vaccine of the APP OMVs, and belongs to the technical field of biology. The preparation method comprises the steps of culturing APP shope strains in vitro by using a culture medium which is in iron ion limit, obtaining acellular cultural supernatant after carrying out centrifugation and 0.22-[mu]m filtration treatment, and preparing the OMVs released by germs through ultracentrifugation, wherein the observation through a transmission electron microscope shows that the diameter of most OMVs is 50 to 100 nm, the OMVs are used as subunit vaccines to carry out secondary intranasal immunization on a mouse, the weight of the OMV immune mouse is increased for a long time, and the visual forms of lungs have no obvious difference from a PBS (Phosphate Buffer Saline) immune group. Meanwhile, an experiment shows that the OMVs are efficient immune stimulants, not only can high-level IgG (Immunoglobulin G) be stimulated to be generated by mouse sera, but also high-level IgA (Immunoglobulin A) can be generated in mouse lungs, mucosal immunity of the mouse lungs is effectively stimulated, and a better application prospect of using the OMVs as the subunit vaccines is expressed.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES

Actinobacillus pleuropneumoniae serotype 2 bacterial strain and its preparation method

ActiveCN102391975AHigh purityHigh immune protection against virusesBacteriaMicroorganism based processesMonosodium glutamateAntigen
The invention discloses an actinobacillus pleuropneumoniae serotype 2 bacterial strain and its preparation method, which is actinobacillus pleuropneumoniae serotype 2XT, wherein the CCTCC NO. is M2011410. The preparation method comprises the following steps: 1) medium preparation, A) weighting yeast powder, glucose, monosodium glutamate, MgSO4, FeSO4.7H2O, dissolving into pure water, regulating pH value and disinfecting; B) weighting NaH2PO4 and K2HPO4 to prepare mother liquor and disinfecting; C) weighting NAD to prepare mother liquor, filtering by a filter membrane; D) mixing the solutions obtained in the step A, the step B and the step C according to amount to obtain the medium; 2) fermentation and culture, a) activating the freeze-drying seeds by NAD-contained TSA plates until single colony is grown out; b) selecting single colony and culturing by shaking a bottle; c) transferring cultured seed liquid to the fermentation medium; d) low stirring at initial fermentation period, and low ventilating; e) raising rotating speed at logarithmic phase and ventilating, and on-line controlling pH value; f) improving dissolved oxygen, and placing into a tank and collecting bacterium. The actinobacillus pleuropneumoniae serotype 2 bacterial strain suitable for preparing inactivated vaccine has the advantages of strong toxicity, good antigen effect, low price, fast mycelium growth, highdensity and easy control.
Owner:WUHAN KEQIAN BIOLOGY CO LTD

Porcine actinobacillus pleuropneumoniae attenuated strain and porcine pleuropneumonia-preventing product prepared from same

The invention discloses a porcine actinobacillus pleuropneumoniae attenuated strain and a porcine pleuropneumonia-preventing product prepared from the same, and relates to the fields of microorganisms and immunology. According to the porcine actinobacillus pleuropneumoniae attenuated strain and the porcine pleuropneumonia-preventing product prepared from the same disclosed by the invention, on the basis of a single mutant strain GS7C, a ureC gene segment in a genome is further deleted, and an apxIII-N gene segment with immunogenicity is inserted, and then the double mutant strains (GS7CA) of apxIIC-/apxIA+ and ureC-/apxIII+ which successfully express ApxIII-N proteins are screened by virtue of a sacB negative gene screening system, and the collection number is CGMCC NO. 10016. Experimental data indicates that, the hemolytic activity and urease activity of the double mutant strains are completely lost, the toxicity is greatly reduced, and stable inheritance can be realized; the attenuated live vaccine prepared by the porcine actinobacillus pleuropneumoniae attenuated strain disclosed by the invention has low toxicity, cross protection activity, high bio-safety and stable quality.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Method for united typing detection of porcine contagious pleuropneumonia antibody and kit

The invention discloses a method for united typing detection of a porcine contagious pleuropneumonia antibody. The method comprises the following steps: firstly preparing actinobacillus pleuropneumoniae polysaccharide antigen and rabbit anti-actinobacillus pleuropneumonia hyper-immune serum, and then purifying; coupling a liquid-phase chip microballoon by utilizing the purified rabbit anti-actinobacillus pleuropneumoniae hyper-immune serum, building a method for typing detection of the liquid-phase chip of the porcine pleuropneumonia antibody according to a double-sandwich ELISA principle, and determining the optimum experimental condition; and finally determining the threshold for positive and negative judgment of the liquid-phase chip through statistical analysis. In addition, the invention also discloses a kit for united typing detection of the liquid-phase chip of the porcine contagious pleuropneumoniae antibody. The invention can simultaneously carry out typing detection of the S1-S7-type serum antibody of porcine contagious pleuropneumonia, and the whole reaction can be completed within 3 hours; and the method has the characteristics of rapidly, sensitively, specifically andsimultaneously detecting a plurality of serum types, thus the method can be used for preliminarily screening entry and exit boars and diagnosing and monitoring porcine contagious pleuropneumoniae in hogpens of China.
Owner:SHANGHAI ENTRY EXIT INSPECTION & QUARANTINE BUREAU OF P R C

Composition for treating swine mycoplasmal pneumonia and porcine contagious pleuropneumonia and preparation method

The invention relates to the field of veterinary drugs, in particulrl to a composition for treating swine mycoplasmal pneumonia and porcine contagious pleuropneumonia and a preparation method thereof. The composition is prepared from, by weight, 15-20 parts of rhizoma atractylodis, 15-20 parts of radix saposhnikoviae, 10-13 parts of liquorice, 10-15 parts of apricot kernels, 30-35 parts of radix astragali, 15-20 parts of radix asteris, 10-15 parts of flos farfarae, 10-15 parts of herba ephedrae, 10-15 parts of periostracum cicada, 10-15 parts of fructus forsythiae and 20-30 parts of lonicera japonica. The composition has the effects of clearing heat, discharging fire, diminishing inflammation, resisting bacteria and the like, all the traditional Chinese medicines are proportioned reasonably to complement and coordinate mutually, the good treatment effect on the swine mycoplasmal pneumonia and the porcine contagious pleuropneumonia is achieved, the treatment course is short, the effects are rapid to achieve, and the cure rate is high; meanwhile, the preparation method of the composition is simple, safe, reliable, free of pollution and residues and easy to popularize.
Owner:DALIAN NATIONALITIES UNIVERSITY

Resistance marker-free attenuated live vaccine against porcine contagious pleuropneumonia (PCP) and application thereof

The invention discloses a resistance marker-free attenuated live vaccine against porcine contagious pleuropneumonia (PCP) and application thereof and further discloses a resistance marker-free actinobacillus pleuropneumoniae (APP) serum 7 type three gene deletion strain used for preparing the vaccine, belonging to the field of bacterial gene engineering technology. The resistance marker-free APP serum 7 type three gene deletion strain APP-Delta clpP-Delta apxIIC-Delta fur is a strain obtained by inactivating coding genes of protease ClpP, an ApxII toxin activator ApxIIC and an iron absorption regulatory protein Fur of APP through oriented homologous recombination and destroys expression of ClpP, ApxIIC and the Fur protein. The three gene deletion strain obtained in the invention has smaller virulence, decreased by more than 100 times, compared with that of a parent strain, and is safe to animals; A pig immunized by using the strain is well protected from attacks by different serum type virulent strains of APP, and all the protection rates are greater than 80%; and the three gene deletion strain can be used as the attenuated live vaccine for immunoprophylaxis of PCP.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI

Actinobacillus pleuropneumoniae serotype 2 bacterial strain and its preparation method

ActiveCN102391975BHigh purityHigh immune protection against virusesBacteriaMicroorganism based processesMonosodium glutamateAntigen
The invention discloses an actinobacillus pleuropneumoniae serotype 2 bacterial strain and its preparation method, which is actinobacillus pleuropneumoniae serotype 2XT, wherein the CCTCC NO. is M2011410. The preparation method comprises the following steps: 1) medium preparation, A) weighting yeast powder, glucose, monosodium glutamate, MgSO4, FeSO4.7H2O, dissolving into pure water, regulating pH value and disinfecting; B) weighting NaH2PO4 and K2HPO4 to prepare mother liquor and disinfecting; C) weighting NAD to prepare mother liquor, filtering by a filter membrane; D) mixing the solutions obtained in the step A, the step B and the step C according to amount to obtain the medium; 2) fermentation and culture, a) activating the freeze-drying seeds by NAD-contained TSA plates until single colony is grown out; b) selecting single colony and culturing by shaking a bottle; c) transferring cultured seed liquid to the fermentation medium; d) low stirring at initial fermentation period, and low ventilating; e) raising rotating speed at logarithmic phase and ventilating, and on-line controlling pH value; f) improving dissolved oxygen, and placing into a tank and collecting bacterium. The actinobacillus pleuropneumoniae serotype 2 bacterial strain suitable for preparing inactivated vaccine has the advantages of strong toxicity, good antigen effect, low price, fast mycelium growth, highdensity and easy control.
Owner:WUHAN KEQIAN BIOLOGY CO LTD

A preparation method of Actinobacillus pleuropneumoniae outer membrane vesicle and vaccine thereof

ActiveCN105420161BExperimental evaluation of immunostimulatory effectsAssessing immunostimulatory effectsAntibacterial agentsBacterial antigen ingredientsIMMUNE STIMULANTSBacteroides
The invention relates to a preparation method of APP (Actinobacillus Pleuropneumoniae) OMVs (Outer Membrane Vesicles) and a vaccine of the APP OMVs, and belongs to the technical field of biology. The preparation method comprises the steps of culturing APP shope strains in vitro by using a culture medium which is in iron ion limit, obtaining acellular cultural supernatant after carrying out centrifugation and 0.22-[mu]m filtration treatment, and preparing the OMVs released by germs through ultracentrifugation, wherein the observation through a transmission electron microscope shows that the diameter of most OMVs is 50 to 100 nm, the OMVs are used as subunit vaccines to carry out secondary intranasal immunization on a mouse, the weight of the OMV immune mouse is increased for a long time, and the visual forms of lungs have no obvious difference from a PBS (Phosphate Buffer Saline) immune group. Meanwhile, an experiment shows that the OMVs are efficient immune stimulants, not only can high-level IgG (Immunoglobulin G) be stimulated to be generated by mouse sera, but also high-level IgA (Immunoglobulin A) can be generated in mouse lungs, mucosal immunity of the mouse lungs is effectively stimulated, and a better application prospect of using the OMVs as the subunit vaccines is expressed.
Owner:JIANGSU ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products